Pioglitazone Therapy Considerations

Introduction to Pioglitazone Therapy

• The American Diabetes Association recommends that pioglitazone should not be used in patients with active heart failure, active bladder cancer, or significant fluid retention due to increased risk of serious adverse outcomes 1

Cardiovascular Considerations

• The American Heart Association suggests that pioglitazone use should be cautious in patients at risk for heart failure and monitor closely 2

Fluid Retention and Edema

• The National Kidney Foundation indicates that pioglitazone is generally not recommended in kidney impairment due to potential for fluid retention 1, 3

Bone Health Concerns

• The American College of Rheumatology recommends that pioglitazone should be used with caution in patients with osteoporosis, falls risk, or fracture history, and consider bone density monitoring in long-term use, especially in older adults 1, 4

Bladder Cancer Risk

• The American Urological Association advises that pioglitazone should not be used in individuals with active bladder cancer, and use caution in those with prior history of bladder cancer 1

Special Populations

• The American Geriatrics Society suggests that pioglitazone should be used very cautiously in older adults on insulin therapy, due to increased risk of falls and fractures 4

Renal Impairment

• The National Kidney Foundation states that no dose adjustment is required based on renal function, but pioglitazone is generally not recommended in kidney impairment due to potential for fluid retention 1, 3